Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    Bone architecture, bone material properties, and bone turnover in non-osteoporotic post-menopausal women with fragility fracture

    Macro- and microarchitectural, bone material property, dynamic histomorphometric, and bone turnover marker data were studied in normal bone mineral density (BMD) post-menopausal women with fragility fracture. ...

    D. B. Kimmel, S. Vennin, A. Desyatova, J. A. Turner in Osteoporosis International (2022)

  2. No Access

    Article

    In premenopausal women with idiopathic osteoporosis, lower bone formation rate is associated with higher body fat and higher IGF-1

    We examined serum IGF-1 in premenopausal IOP, finding relationships that were opposite to those expected: higher IGF-1 was associated with lower bone formation and higher body fat, and lower BMD response to terip...

    T.G. Goetz, N. Nair, S. Shiau, R.R. Recker, J.M. Lappe in Osteoporosis International (2022)

  3. No Access

    Article

    Effect of Macroanatomic Bone Type and Estrogen Loss on Osteocyte Lacunar Properties in Healthy Adult Women

    This is the first study to examine clinical human bone specimens by three-dimensional imaging to characterize osteocyte lacunar properties as a function of macroanatomic bone type and estrogen loss. We applied...

    Mohammed P. Akhter, D. B. Kimmel, J. M. Lappe in Calcified Tissue International (2017)

  4. No Access

    Article

    Marrow adiposity assessed on transiliac crest biopsy samples correlates with noninvasive measurement of marrow adiposity by proton magnetic resonance spectroscopy (1H-MRS) at the spine but not the femur

    Measurement of marrow fat (MF) is important to the study of bone fragility. We measured MF on iliac biopsies and by spine/hip magnetic resonance spectroscopy in the same subjects. Noninvasively assessed spine ...

    A. Cohen, W. Shen, D. W. Dempster, H. Zhou, R. R. Recker in Osteoporosis International (2015)

  5. No Access

    Article

    Self-reported calcium use in a cohort of postmenopausal women receiving osteoporosis therapy: results from POSSIBLE US™

    Calcium use was common and remained high among women on osteoporosis therapy. Use of calcium-supplemented pharmacologic therapy increased from 65.1 to 76.0 % in these women (mean follow-up, 27.5 months). Over ...

    E. Barrett-Connor, S. W. Wade, R. W. Downs, T. Ganiats in Osteoporosis International (2015)

  6. No Access

    Article

    Bone safety with risedronate: histomorphometric studies at different dose levels and exposure

    This report describes bone safety and histomorphometric data across different dose levels and dosing frequencies of risedronate. Normal bone structure and histomorphometric data were observed, with ongoing bon...

    R. R. Recker, L.-G. Ste-Marie, P. Chavassieux, M. R. McClung in Osteoporosis International (2015)

  7. No Access

    Article

    Relationship of Bone Mineralization Density Distribution (BMDD) in Cortical and Cancellous Bone Within the Iliac Crest of Healthy Premenopausal Women

    Bone mineralization density distribution (BMDD) is an important determinant of bone mechanical properties. The most available skeletal site for access to the BMDD is the iliac crest. Compared to cancellous bo...

    B. M. Misof, D. W. Dempster, Hua Zhou, P. Roschger in Calcified Tissue International (2014)

  8. No Access

    Article

    Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies

    Ibandronate reduces the risk of vertebral and non-vertebral fractures versus placebo in postmenopausal women with osteoporosis. This analysis, in which fractures were reported as safety events, showed that lon...

    P. D. Miller, R. R. Recker, S. Harris, S. Silverman in Osteoporosis International (2014)

  9. Article

    Open Access

    Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years

    Bone mineral density response to once weekly delayed-release formulation of risedronate, given before or following breakfast, was non-inferior to that seen with traditional immediate-release risedronate given ...

    M. R. McClung, A. Balske, D. E. Burgio, D. Wenderoth in Osteoporosis International (2013)

  10. No Access

    Article

    Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study

    The long-term efficacy and safety of once-monthly ibandronate were studied in this extension to the 2-year Monthly Oral Ibandronate in Ladies (MOBILE) trial. Over 5 years, lumbar spine bone mineral density (BM...

    P. D. Miller, R. R. Recker, J.-Y. Reginster, B. J. Riis in Osteoporosis International (2012)

  11. No Access

    Article

    Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension

    Long-term bone mineral density (BMD) gains, bone marker levels, and safety of 3 mg quarterly intravenous (IV) ibandronate were studied in this 3-year extension to the Dosing IntraVenous Administration (DIVA) t...

    G. Bianchi, E. Czerwinski, A. Kenwright, A. Burdeska in Osteoporosis International (2012)

  12. No Access

    Article

    Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density

    In men, idiopathic osteoporosis (IOP) is often associated with low serum insulin-like growth factor (IGF-1) and reduced bone formation. The characteristics of premenopausal women with IOP are not well defined....

    A. Cohen, R. R. Recker, J. Lappe, D. W. Dempster, S. Cremers in Osteoporosis International (2012)

  13. Article

    Open Access

    Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet

    Dosing regimens of oral bisphosphonates are inconvenient and contribute to poor compliance. The bone mineral density response to a once weekly delayed-release formulation of risedronate given before or followi...

    M. R. McClung, P. D. Miller, J. P. Brown, J. Zanchetta in Osteoporosis International (2012)

  14. No Access

    Article

    Disuse-related decline in trabecular bone structure

    Sedentary life style may degrade bone mass and microstructure resulting in osteoporosis. We characterized trabecular bone structural properties to determine if the LRP5 G171V mutation will protect against disu...

    M. P. Akhter, G. K. Alvarez, D. M. Cullen in Biomechanics and Modeling in Mechanobiology (2011)

  15. Article

    Erratum to: Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians

    F.-Y. Deng, L.-J. Zhao, Y.-F. Pei, B.-Y. Sha, X.-G. Liu in Osteoporosis International (2010)

  16. No Access

    Article

    Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians

    Osteoporotic fracture (OF) is a serious outcome of osteoporosis. Important risk factors for OF include reduced bone mineral density and unstable bone structure. This genome-wide copy number variation associati...

    F.-Y. Deng, L.-J. Zhao, Y.-F. Pei, B.-Y. Sha, X.-G. Liu in Osteoporosis International (2010)

  17. No Access

    Article

    Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy

    We compared microarchitecture and mechanical competence parameters measured by high-resolution peripheral quantitative computed tomography (HR-pQCT) and finite-element analysis of radius and tibia to those mea...

    A. Cohen, D. W. Dempster, R. Müller, X. E. Guo in Osteoporosis International (2010)

  18. No Access

    Article

    Association analyses of vitamin D-binding protein gene with compression strength index variation in Caucasian nuclear families

    This study was conducted to test whether there exists an association between vitamin D-binding protein (DBP) gene and compression strength index (CSI) phenotype. Candidate gene association analyses were conducted...

    X.-H. Xu, D.-H. **ong, X.-G. Liu, Y. Guo, Y. Chen, J. Zhao in Osteoporosis International (2010)

  19. No Access

    Article

    Genome-wide association analyses suggested a novel mechanism for smoking behavior regulated by IL15

    Cigarette smoking is the leading preventable cause of death in the United States. Although smoking behavior has a significant genetic determination, the specific genes and associated mechanisms underlying the ...

    Y-Z Liu, Y-F Pei, Y-F Guo, L Wang, X-G Liu, H Yan, D-H **ong in Molecular Psychiatry (2009)

  20. No Access

    Article

    Comparison of whole genome linkage scans in premenopausal and postmenopausal women: no bone-loss-specific QTLs were implicated

    This study was conducted to investigate if there exist bone-loss-specific quantitative trait loci (QTLs) for females. Genome-wide linkage scans were conducted in total, premenopausal, and postmenopausal women,...

    H. Yan, Y.-J. Liu, Q. Zhou, P. **ao, R. R. Recker, H.-W. Deng in Osteoporosis International (2009)

previous disabled Page of 3